Looking for a gaming smartphone under Rs 20,000? Check out these options from Motorola, Samsung, iQOO, and Nothing to Redmi. Gamers alert! If you are looking for a new smartphone in the budget segment which can take off your day-to-day life tasks along with your gaming sessions, then here are some considerations that you must check out before buying a new phone. A gaming phone must have a large battery, a powerful processor, and a good display for a better viewing experience while gaming. Check out the options from Motorola, Samsung, iQOO, and Nothing to Redmi for gaming smartphones under Rs 20,000. Budget Phones Under 2000 For Gaming Moto Edge 50 Neo The Moto Edge 50 Neo is on Flipkart for Rs 21,999 as the offer price, but there is also an available offer in which it can be purchased for Rs 19,999 with a Rs 2,000 card discount. It is powered by Mediatek Dimensity 7300 chipset, and you can also have the benefit of a stock Android experience. The phone features three rear cameras, including a 50MP main camera, a 13 MP Ultra Wide camera, and a 10MP Telephoto camera. Samsung Galaxy A15 5G The Samsung Galaxy A15 5G seems to be ideal for budget-conscious individuals as it costs Rs 14,998 and is available on Amazon. Powered by MediaTek Dimensity 6100+ processor, it can handle your casual gaming. It boasts a tri-camera array with a 50MP main camera, a 5MP camera with an ultra-wide-angle lens, and a macro lens with 2MP. iQOO Z9 The iQOO Z9 is listed for Rs 18,498 on Amazon and is powered by the MediaTek Dimensity 7200 processor, built using TSMC’s 2nd Gen 4nm process with a 2.8GHz clock speed. Its camera setup includes a 50MP Sony IMX882 OIS sensor that supports 4K video recording, Super Night mode, 2x Portrait Zoom, and a 50MP UHD mode for sharp photos and videos. Nothing Phone 2a The Nothing Phone 2a costs Rs 23,999 on Flipkart but can be purchased for Rs 20,999 with a Rs 3,000 card discount. It’s powered by the MediaTek Dimensity 7200 Pro processor, has a 6.7-inch Full HD+ display, and a 5000mAh battery for all-day usage. It features two 50MP cameras with Optical Image Stabilisation (OIS) and a 32MP front-facing camera for selfies. Redmi Note 13 Pro On Amazon, the price is tagged at Rs 18,250 for the Redmi Note 13 Pro. Powered by Snapdragon 7s Gen 2 chipset, the device has a 1.5K 6.67-inch AMOLED display that supports 120Hz refresh rate, Dolby Vision, and comes with Corning Gorilla Glass Victus. Click for more latest Mobile Phone news . Also get top headlines and latest news from India and around the world at News9. Divya is a Senior Sub-Editor with about 3 years of experience in journalism and content writing. Before joining News9live, she had contributed to Times Now and Hindustan Times, where she focused on tech reporting and reviewing gadgets. When she's not working, you can find her indulging in Netflix, expressing her creativity through painting, and dancing.

Hamas/Fatah reign will enure attacks

Half of people with HIV in the United States are living in places that are vulnerable to extreme weather and climate disasters, according to a new analysis from the left-leaning Center for American Progress (CAP). The report from CAP released Wednesday finds that the areas of the country where HIV is being diagnosed at disproportionately high rates are also places most at risk of disasters. The analysis used data from the Ending the HIV Epidemic in the U.S. (EHE) program, a federal program that aims to reduce the rate of new HIV infections, and the Federal Emergency Management Agency (FEMA) national risk index. FEMA’s tool takes into account the frequency of disasters, but also the vulnerability of the population, accounting for certain at-risk demographics like low-income and socially disadvantaged people. Fifty locations, including 48 counties, Washington, D.C., and San Juan, Puerto Rico, have been designated by EHE as high-priority areas to combat HIV because they are where more than 50 percent of new HIV cases occur. On average, those places had a national risk index score of 96.8 out of a 100. “It is not surprising that those most at-risk live in areas particularly vulnerable to extreme weather and climate events. That is true for many other climate-sensitive health outcomes,” said Kristie Ebi, professor of global health at the University of Washington, who reviewed the analysis. “The poor and marginalized are generally at higher risk and often live in less desirable locations that are less desirable because of vulnerability to extreme weather and climate events.” Haley Norris, policy analyst with CAP and author of the report, said what stood out to them was the variability in threats faced by the different parts of the country. On the West Coast, wildfires cause issues for people with HIV because many develop lung conditions that are exacerbated by wildfire smoke. In the South and Northeast, flooding and hurricanes pose unique health issues for people with HIV by making it more difficult to access medical care. All three of these types of climate disasters are becoming more destructive due to climate change. “We’re seeing extreme weather and climate events that are quite far outside of historic experience,” Ebi said, pointing to flooding in Asheville, North Carolina, as one recent example. For those with HIV, those extreme events are making it harder to stay on track with their medications, which stop the disease from progressing to AIDS and prevent transmission to others. Vatsana Chanthala is director of the New Orleans Health Department’s Ryan White HIV/AIDS Program, a federal initiative that provides funding for clinics and treatments that support low-income people. New Orleans is located in one of the priority jurisdictions to combat new HIV infections. After Hurricane Ida in 2021, her team surveyed patients in the program to gain a better understanding of how the disaster may have disrupted their care or access to medications. HIV treatment involves taking antiretrovirals daily or bimonthly injections to suppress the virus and keep it at a level that prevents it from spreading. After Ida, pharmacies closed due to damage; electricity was also out for nearly two weeks in parts of the city, making it difficult to contact pharmacies to refill lost prescriptions or others that had run out, Chanthala said. The high cost of the drugs means some pharmacies were hesitant to fill prescriptions, worried that people wouldn’t come to pick them up. The cost of the drugs were also an issue for those who evacuated: Many did not know that they could use their insurance to cover medication out of state, so they did not attempt to purchase the medication due to out-of-pocket costs, Chanthala found. Of the 194 patients surveyed, 30 percent of those who evacuated said they had trouble accessing care, and of those who stayed in New Orleans, 32 percent also had trouble accessing care. Another barrier to taking medications is the stigma surrounding HIV. In times of disaster, many people evacuate to the homes of family and friends, and some people in the survey said their family was unaware they had HIV. “There’s still a lot of fear with HIV and so many clients don’t disclose their status,” Chanthala said. “And so they find ways to hide their medications, and if they’re around people, they’re less likely to take those medications out.” Norris, the author of the CAP report, said one study on HIV care and wildfires in California also found that people expressed fear of disclosing they had the disease. “These are people who are going through extremely stressful, life-destroying situations and they have to do the emotional calculation of, ‘will disclosing this make me less safe?’” they said. “That is the hardest part of the puzzle for us to figure out. It is not just about access, it is the reality that HIV stigma is still very alive and well and still very powerful.” The risk associated with not taking medications is high for people with HIV. If someone stops taking their antiretrovirals, also known as ART, or if they run out of medication, their viral load will go up over time, said Dr. Paula Seal, who works at the HIV Outpatient Clinic at the University Medical Center New Orleans. The length of time it would take for that to happen depends on the individual patient and when they were diagnosed with HIV. But Seal said they stress the importance of patients staying on their medication. “When you have trouble is when patients are running out of medications because if they don’t have enough medicine, then they start skipping doses to make it last longer, that’s when we run into problems, and then the virus can become resistant to those medications,” Seal said. To offset those risks, Seal and other providers follow a hurricane preparedness protocol, talking with patients every year before hurricane season hits and urging them to refill their prescriptions. In many instances people can get up to 90 days covered by insurance, which could last through a hurricane season. Seal also provides numbers to pharmacies they can contact if something happens to their medication. This October, the Biden administration updated its guidelines for providers who are treating people with HIV who have been displaced, Norris said. The new guidelines walk providers, who might not have expertise in treating HIV, through how to assess and prescribe medication for new patients who otherwise may have disruption in their care. “Providing ART is very complex, it’s really really good that they were able to get that out when they did,” they said. One way that the Ryan White Program could become more nimble is by having its services follow the enrolled patients, Chanthala said. Currently patients at the Ryan White clinics have access to wrap-around services, like transportation and help with housing, but they lose that support if they evacuate. “Medications are important, and adherence is important. But if a person needs food, needs a place to stay, that’s going to be first on their minds,” she said. Currently these supports are not provided through money directly, but Chanthala thinks that in disaster situations having that flexibility to provide funds for people with high medical needs could also help: “If they can’t afford gas to get out of the area, they aren’t going to evacuate.”None

Kylie Kelce says she’s ‘not going to stop cursing’ in front of kids in trailer for new podcastWASHINGTON D.C., DC — President-elect Donald Trump on Friday nominated Dr. Marty Makary to lead the Food and Drug Administration , selecting a surgeon and author who gained national attention for opposing vaccine mandates and some other public health measures during the COVID-19 pandemic . Makary, a professor at Johns Hopkins University, is the latest in a string of Trump nominees who have declared the U.S. health system “broken," vowing a shakeup. As part of a flurry of nominations late Friday night, Trump also tapped doctor and former Republican Rep. Dave Weldon of Florida to lead the Centers for Disease Control and Prevention. Fox News contributor Janette Nesheiwat, meanwhile, is set to be the nation's next surgeon general. Some of Makary's views align closely with the man who is poised to be his boss — prominent environmental lawyer and anti-vaccine organizer Robert F. Kennedy Jr., whom Trump put forward as the next U.S. Department of Health and Human Services secretary. In books and articles, Makary has decried the overprescribing of drugs, the use of pesticides on foods and the undue influence of pharmaceutical and insurance companies over doctors and government regulators, points that Kennedy has also harped on for years. Trump said Makary, trained as a surgeon and cancer specialist, “will restore FDA to the gold standard of scientific research, and cut the bureaucratic red tape at the agency to make sure Americans get the medical cures and treatments they deserve.” Headquartered in the Maryland suburbs outside Washington, the 18,000 employees of the FDA are responsible for the safety and effectiveness of prescription drugs , vaccines and medical devices as well as a swath of other consumer goods, including food , cosmetics and vaping products . Altogether those products represent an estimated 20% of U.S. consumer spending annually, or $2.6 trillion. Makary gained prominence on Fox News and other conservative outlets for his contrarian views during the COVID-19 pandemic. He questioned the need for masking and, though not opposed to the COVID-19 vaccine, had concerns about booster vaccinations in young children. He was part of a vocal group of physicians calling for greater emphasis on herd immunity to stop the virus, or the idea that mass infections would quickly lead to population-level protection. The Centers for Disease Control and Prevention estimated that COVID-19 vaccinations prevented more than 686,000 U.S. deaths in 2020 and 2021 alone. While children faced much lower rates of hospitalization and death from the virus, medical societies including the American Academy of Pediatrics concluded that vaccinations significantly reduced severe disease in the age group. Makary has lamented how drugmakers used misleading data to urge doctors to prescribe OxyContin and other opioids as low-risk, non-addictive pain relievers. That marketing was permitted under FDA-approved labeling from the 1990s, suggesting the drugs were safe for common ailments like back pain. In more recent years, the FDA has come under fire for approving drugs for Alzheimer's , ALS and other conditions based on incomplete data that failed to show meaningful benefits for patients. A push toward greater scrutiny of drug safety and effectiveness would be a major reversal at FDA, which for decades has focused on speedier drug approvals . That trend has been fueled by industry lobbying and fees paid by drugmakers to help the FDA hire additional reviewers. Kennedy has proposed ending those payments, which would require billions in new funding from the federal budget. Other administration priorities would likely run into similar roadblocks. For instance, Kennedy wants to bar drugmakers from advertising on TV , a multibillion-dollar market that supports many TV and cable networks. The Supreme Court and other conservative judges would likely overturn such a ban on First Amendment grounds that protect commercial speech, experts note. Less is known about Trump's pick for the Atlanta-based CDC, which develops vaccines and monitors for infectious disease outbreaks. Weldon is a staunch, self-described “pro-life” Republican. Legislation he introduced more than 20 years ago outlawed human cloning. He also brokered a deal with lawmakers to bar patents on human organisms, including genetically engineered embryos. Weldon also advocated against the removal of the feeding tube for Terri Schiavo, a Florida woman whose family battle over her vegetative state turned into a national debate. Weldon's nomination is likely to placate some anti-abortion advocates, who have been concerned about Trump's nomination of Kennedy, a longtime Democrat and proponent of abortion rights, as the nation's top health official. Weldon retired from his congressional seat in 2008, after 14 years in public office. Earlier this year, he lost in a GOP primary for a seat in the Florida Legislature. If he's confirmed, he'll be in charge of more than 13,000 employees and nearly 13,000 other contract workers. Nesheiwat, meanwhile, will oversee 6,000 U.S. Public Health Service Corps members if the Republican-controlled Senate approves her nomination as the surgeon general. She is a medical director for an urgent care company in New York. She appears regularly on Fox News and has expressed frequent support for Trump, sharing photos of them together on her social media pages. Surgeons general also have the power to issue advisories, warning of public health threats in the U.S. Those advisories can influence how the government, public and medical community respond to health crises in the country. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

NoneNone

Former Scheels leader honored with North Dakota Rough Rider Award

Iran said Friday it would launch a series of “new and advanced” centrifuges in response to a resolution adopted by the UN nuclear watchdog that censures Tehran for what the agency called lack of cooperation. The censure motion brought by Britain, France, Germany, and the United States at the 35-nation board of the International Atomic Energy Agency (IAEA) follows a similar one in June. The resolution — which China, Russia and Burkina Faso voted against — was carried with 19 votes in favour, 12 abstentions and Venezuela not participating, two diplomats told AFP. “The head of the Atomic Energy Organization of Iran issued an order to take effective measures, including launching a significant series of new and advanced centrifuges of various types,” a joint statement by the organisation and Iran’s foreign ministry said. Centrifuges are the machines that enrich uranium transformed into gas by rotating it at very high speed, increasing the proportion of fissile isotope material (U-235). “At the same time, technical and safeguards cooperation with the IAEA will continue, as in the past” and within the framework of agreements made by Iran, the joint Iranian statement added. Iran’s retaliatory measures “are reversible if this (Western) hostile action is withdrawn or negotiations are opened,” Tehran-based political analyst Hadi Mohammadi told AFP. The resolution comes with tensions running high over Iran’s atomic programme, with critics fearing that Tehran is attempting to develop a nuclear weapon — a claim the Islamic republic has repeatedly denied.

None